According to IMARC Group, the global Cord Blood Banking Services Market size was valued at USD 2.2 Billion in 2025 and is projected to reach USD 4.8 Billion by 2034, expanding at a CAGR of 8.66% during 2026–2034. This robust Cord Blood Banking Services Market Growth reflects rising awareness of stem cell therapies, increasing prevalence of genetic disorders, advancements in regenerative medicine, and growing adoption of private banking services across global healthcare systems.

Cord Blood Banking Services Industry Overview

The cord blood banking services industry sits at the intersection of biotechnology, healthcare delivery, and future-focused medicine. Cord blood — the blood remaining in the umbilical cord and placenta after birth — contains valuable hematopoietic stem cells (HSCs) capable of regenerating blood and immune systems. These cells have clinically proven applications in treating conditions including leukemia, lymphoma, sickle cell anemia, thalassemia, and immune disorders.

Cord blood banking services encompass the entire lifecycle from collection and processing to long-term cryopreservation and retrieval.

Key service channels include:

●        Public Cord Blood Banks: Donations stored for any matched patient in need, supported by government and non-profit organizations

●        Private Cord Blood Banks: Family-exclusive storage for personalized future medical use, driven by rising disposable incomes and personalized medicine trends

The market segments by component (Cord Blood and Cord Tissue), storage services (public and private banks), and application — spanning cancer diseases, diabetes, blood disorders, immune conditions, and metabolic diseases.

Global Cord Blood Banking Services Market Size & Industry Statistics

The following Cord Blood Banking Services Market Size statistics are drawn from IMARC Group's comprehensive market analysis:

Request for a Sample Report for Detailed Cord Blood Banking Services Market Share Evaluation: https://www.imarcgroup.com/cord-blood-banking-services-market/requestsample

Key Market Drivers & Cord Blood Banking Services Market Trends in 2026

Several powerful forces are shaping the Cord Blood Banking Services Market Trends and fueling sustained expansion across global healthcare markets:

1. Rising Awareness of Stem Cell Therapies

Growing public knowledge of cord blood's potential in treating over 80 diseases — including leukemia, lymphoma, and autoimmune disorders — is a primary catalyst. According to the American Cancer Society, an estimated 22,010 Americans will receive an AML diagnosis in 2025. Educational campaigns by organizations such as the Cord Blood Association and National Marrow Donor Program are encouraging parents to preserve their newborn's stem cells, directly fueling Cord Blood Banking Services Market Growth from the demand side.

2. Increasing Prevalence of Genetic and Autoimmune Disorders

The rising incidence of hemoglobinopathies, sickle cell anemia, and metabolic disorders is driving families to proactively store cord blood. Industry data indicates that approximately 300,000–400,000 children are born annually with severe hemoglobinopathies, while 4.4 in every 10,000 live births are affected by thalassemia. Researchers are also exploring mesenchymal stem cells (MSCs) from cord blood for treating diabetes, cerebral palsy, and neurodegenerative diseases, broadly expanding the clinical appeal of banking services.

3. Technological Advancements in Cryopreservation and Stem Cell Processing

Innovations in cryopreservation, automated cell separation, AI-driven sample tracking, and biorepository management systems are enhancing the efficiency and long-term viability of stored cord blood samples. In July 2024, NMDP BioTherapies launched a Cord Blood Bank Alliance (CBBA) with an inventory of over 200,000 pre-identified cord blood units optimized for NK cell therapies — a significant technology milestone reflecting key Cord Blood Banking Services Market Trends toward regenerative cell therapy development.

4. Expanding Private Cord Blood Banking Adoption

Private cord blood banks currently hold approximately 94.6% of the Cord Blood Banking Services Market Share in 2025, driven by rising disposable incomes, personalized healthcare trends, and the appeal of exclusive stem cell storage. Parents increasingly prefer private banking for guaranteed family access to stored cells. Advanced storage plans, flexible financing options, and premium processing services further reinforce private banks' dominant Cord Blood Banking Services Market Share position.

5. Government Initiatives and Regulatory Support

Government-backed public cord blood banks, regulatory approvals, and research funding are expanding the accessibility and credibility of cord blood banking. In November 2024, Qatar Foundation's Sidra Medicine launched Qatar's first local cord blood banking service. In May 2024, Abu Dhabi's Department of Health and M42 unveiled the region's largest hybrid cord blood bank — part of Abu Dhabi's vision to become a global biobanking hub — reflecting strong institutional tailwinds for the market.

6. Growing Demand from Emerging Markets and Rising Birth Rates

Asia Pacific is a fast-growing regional contributor, fueled by a rapidly expanding elderly population projected to reach approximately 1.3 billion by 2050, rising cancer incidence (169.1 per 100,000 in Asia in 2020), and improving healthcare infrastructure. Increasing birth rates in developing economies further support new cord blood banking service subscriptions, sustaining long-term Cord Blood Banking Services Market Growth through the forecast period.

Key Market Segmentation

By Component

●        Cord Blood – Largest Segment (~62.5% share in 2025): Cord blood dominates due to its rich concentration of HSCs with clinically approved applications in lymphoma, leukemia, and sickle cell anemia. Its ease of collection, superior cryopreservation outcomes, and lower graft-versus-host disease (GVHD) risk make it the preferred option for transplantation.

●        Cord Tissue: Contains mesenchymal stem cells (MSCs) with growing research applications in regenerative medicine and musculoskeletal therapies, representing a fast-emerging segment.

By Storage Services

●        Private Cord Blood Banks – Largest (~94.6% share in 2025): Private banks dominate, driven by personalized storage demand, customized plans, advanced processing, and long-term security assurances. Higher marketing efforts and financing options further reinforce their market position.

●        Public Cord Blood Banks: Supported by government and non-profit bodies, offering storage for unrelated patient matching through national donor programs such as the NMDP.

By Application

●        Diabetes – Largest (~28% share in 2025): The global diabetes burden and research into cord blood MSCs' ability to regenerate pancreatic beta cells and modulate immune responses drive this segment's leadership position.

●        Cancer Disease: Significant adoption for leukemia and lymphoma treatments via HSC transplantation.

●        Blood Disease: Sickle cell anemia, thalassemia, and aplastic anemia treatment applications.

●        Immune Disorders: Growing clinical applications in autoimmune condition management.

●        Metabolic Disorders & Others: Expanding clinical trial activity in neurodegenerative and metabolic disease therapies.

Regional Market Analysis

Connect for Detailed Segmentation Analysis – Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=5744&flag=C

Leading Players in the Cord Blood Banking Services Industry

The global Cord Blood Banking Services Market features an active competitive landscape of specialized stem cell storage providers and healthcare biotechnology firms. Key companies covered in the IMARC Group report include:

●        Alphacord LLC

●        Americord Registry LLC

●        ATCC

●        California Cryobank

●        Cordlife Group Limited

●        Cryo-Cell International Inc.

●        Global Cord Blood Corporation

●        LifeBank

●        LifeCell International Pvt. Ltd.

●        National Cord Blood Program

●        Norton Healthcare Inc.

●        PerkinElmer Inc.

●        StemCyte India Therapeutics Pvt. Ltd.

The report includes comprehensive competitive analysis covering market structure, player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant.

Latest Industry Developments

November 2024 – Sidra Medicine (Qatar Foundation)

Sidra Medicine launched Qatar's first local cord blood banking service, enabling families to store their newborns' stem cells. The service targets treatment of malignancies, blood disorders, and immune system diseases using hematopoietic stem cells derived from cord blood.

September 2024 – Cordlife Group

Cordlife Group received approval to resume cord blood banking in Singapore under controlled conditions, introducing an enhanced processing and storage facility with improved operational protocols and an advanced laboratory monitoring system.

May 2024 – Abu Dhabi Biobank (DoH & M42 Partnership)

The Department of Health – Abu Dhabi and M42 launched the Abu Dhabi Biobank, including the region's largest hybrid cord blood bank. The initiative supports medical research, drug discovery, and personalized healthcare as a centerpiece of Abu Dhabi's biobanking hub vision.

May 2024 – StemCyte & California State Umbilical Cord Blood Collection Program

StemCyte renewed its partnership with the California State Umbilical Cord Blood Collection Program (CA-UCBCP) and UC Davis Health, enhancing ethnic diversity in cord blood banking with plans for new hospital collection sites in Palm Springs and Sacramento.

About Us

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Technology, Construction, Healthcare, Energy, Food & Beverages, and more.

Contact Us

IMARC Group

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104